Unifi (UFI) EBITDA Margin (2010 - 2026)

Unifi (UFI) posted EBITDA Margin of 0.09% for Q1 2026, up 98.5% sequentially from 6.0% in Q4 2025, and up 937.0% YoY from 0.01% in Q1 2025.

Unifi (UFI) EBITDA Margin (2010 - 2026) Analysis & Trends

Unifi has reported EBITDA Margin for 17 years, with the latest figure at 0.09% in Q1 2026.

Quarterly EBITDA Margin rose 937.0% year-over-year to 0.09% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.36% (up 395.0% YoY) and the FY2025 annual result came in at 1.67%, up 476.0% from the prior year.
EBITDA Margin climbed to 0.09% in Q1 2026 per UFI's latest filing, from 6.0% in the prior quarter.
Over five years, EBITDA Margin peaked at 10.91% in Q2 2025 and troughed at 14.55% in Q1 2023.
A 5-year average of 4.05% and a median of 4.65% in 2024 frame the typical range for EBITDA Margin.
The sharpest annual moves came in 2023 and 2025: EBITDA Margin tumbled 1683 bps in 2023, then surged 1144 bps in 2025.
Over 5 years, EBITDA Margin stood at 2.62% in 2022, then sank by 393 bps to 12.89% in 2023, then jumped by 58 bps to 5.45% in 2024, then retreated by 10 bps to 6.0% in 2025, then jumped by 98 bps to 0.09% in 2026.
According to Business Quant data, EBITDA Margin over the past three periods registered 0.09%, 6.0%, and 7.1% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin (Qtr)
1	Albany International	1.67 Bn	1.59 Bn	107.90 Mn	9.75%
2	SMJ International Holdings	291.52 Mn	271.89 Mn	-	-
3	Unifi	140.50 Mn	112.02 Mn	9.12 Mn	-0.09%
4	Culp	41.62 Mn	41.62 Mn	-	-
5	Ping An Biomedical	2.49 Mn	-2.63 Mn	-	-

Download Data